NeoSome Life Sciences

Executive Summary

NeoSome Life Sciences is a preclinical contract research organization (CRO) headquartered in Billerica, Massachusetts, with a focus on oncology and infectious disease. Founded in 2018, the company operates a 30,000 sq. ft. AAALAC-accredited facility, offering services from in vitro assays and proof-of-concept studies to drug efficacy evaluations in animal models. As a service provider, NeoSome generates revenue through client-sponsored research, positioning it as a steady, lower-risk entity compared to drug developers. The company benefits from the growing outsourcing trend in pharmaceutical R&D, though its private status limits visibility into financial performance. Key strengths include its specialized oncology and infectious disease focus, accredited facility, and comprehensive preclinical capabilities.

Upcoming Catalysts (preview)

• TBDAnnouncement of New Client Contracts or Partnerships70% success
• TBDFacility Expansion or Capacity Upgrade50% success
• TBDDisclosure of Financial Metrics or Funding Round40% success